Fármacos utilizados en reproducción asistida y riesgo de cáncer de mama

The present article reviews the studies carried out on this subject. A literature search of articles published in the previous 15 years was performed in Pubmed and bibliographic references were retrieved from relevant articles published in the main scientific journals. We conclude that further studies with longer follow- up periods and more meticulous designs (with greater statistical power and adequate populations) are required. Such studies should specify details on the type of sterility in each patient, as well as the type of drug used and the dose.